Dashboard
Manage Tickers

ENFN


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Clearwater Analytics Successfully Complete...
04/21/2025 20:19:18

Clearwater Will Deliver Industry's First Unified, Cloud-Native Front-to-Back Platform for Institutional InvestorsClearwater...

Core News & Articles
Clearwater Analytics and Enfusion Releases...
04/02/2025 20:19:33

Clearwater Analytics (NYSE:CWAN) ("Clearwater") and Enfusion, Inc. (NYSE:ENFN) ("Enfusion") today announced tha...

Core News & Articles
Reported Earlier, Clearwater-Enfusion Deal...
02/27/2025 07:23:51

12-information-technology-stocks-moving-in-fridays-pre-market-session
12 Information Technology Stocks Moving In...
01/17/2025 21:05:36

12-information-technology-stocks-moving-in-fridays-pre-market-session
12 Information Technology Stocks Moving In...
01/17/2025 12:05:33

william-blair-downgrades-enfusion-to-market-perform
William Blair Downgrades Enfusion to Marke...
01/13/2025 19:23:21

William Blair analyst Bhavan Suri downgrades Enfusion (NYSE:ENFN) from Outperform to Market Perform.

Core News & Articles
Clearwater Analytics to Acquire Enfusion f...
01/13/2025 11:41:08

Clearwater Analytics (NYSE:CWAN) ("Clearwater") and Enfusion, Inc. (NYSE:ENFN) ("Enfusion") today announced the...

this-analyst-with-85-accuracy-rate-sees-around-10-upside-in-alphabet---here-are-5-stock-picks-for-2024-from-wall-streets-most-accurate-analysts
This Analyst With 85% Accuracy Rate Sees A...
01/02/2025 12:45:39

this-analyst-with-82-accuracy-rate-sees-around-28-upside-in-apple---here-are-5-stock-picks-for-last-week-from-wall-streets-most-accurate-analysts
This Analyst With 82% Accuracy Rate Sees A...
12/30/2024 12:45:15

piper-sandler-maintains-neutral-on-enfusion-raises-price-target-to-115
Piper Sandler Maintains Neutral on Enfusio...
12/23/2024 12:28:03

Piper Sandler analyst Sumeet Mody maintains Enfusion (NYSE:ENFN) with a Neutral and raises the price target from $10 to $11.5.

12-information-technology-stocks-moving-in-thursdays-pre-market-session
12 Information Technology Stocks Moving In...
12/19/2024 21:06:29

stifel-maintains-buy-on-enfusion-raises-price-target-to-13
Stifel Maintains Buy on Enfusion, Raises P...
12/18/2024 17:13:17

Stifel analyst Parker Lane maintains Enfusion (NYSE:ENFN) with a Buy and raises the price target from $11 to $13.

enfusion-narrows-fy2024-sales-guidance-from-20000m-21000m-to-20200m-20500m--vs-est-2048m
Enfusion Narrows FY2024 Sales Guidance fro...
11/04/2024 12:40:53

Enfusion (NYSE:ENFN) narrows FY2024 sales outlook from $200.00 million-210.00 million to $202.00 million-205.00 million.

enfusion-q3-adj-005-misses-006-estimate-sales-5117m-miss-5217m-estimate
Enfusion Q3 Adj $0.05 Misses $0.06 Estimat...
11/04/2024 12:35:32

Enfusion (NYSE:ENFN) reported quarterly earnings of $0.05 per share which missed the analyst consensus estimate of $0.06 by 16....

enfusion-is-interviewing-investment-banks-to-explore-options-including-a-potential-sale-sources-say
Enfusion Is Interviewing Investment Banks ...
09/20/2024 17:47:37

-Reuters

enfusion-continues-to-expect-fy24-gaap-revenues-of-200m---210m-est-205565m
Enfusion Continues To Expect FY24 GAAP Rev...
08/06/2024 11:48:29

enfusion-q2-2024-adj-eps-005-misses-006-estimate-sales-49455m-miss-50046m-estimate
Enfusion Q2 2024 Adj. EPS $0.05 Misses $0....
08/06/2024 11:39:36

Enfusion (NYSE:ENFN) reported quarterly earnings of $0.05 per share which missed the analyst consensus estimate of $0.06 by 16....

enfusion-q1-2024-adj-eps-006-beats-004-estimate-sales-48052m-beat-47616m-estimate
Enfusion Q1 2024 Adj EPS $0.06 Beats $0.04...
05/09/2024 11:34:40

Enfusion (NYSE:ENFN) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.04 by 50 pe...

watching-enfusion-spruce-point-capital-management-issues-short-report-on-co-says-based-on-our-investigation-we-estimate-a-40-to-60-downside-risk
Watching Enfusion; Spruce Point Capital Ma...
03/14/2024 13:32:05

https://www.sprucepointcap.com/research/enfusion-inc After conducting a forensic review of Enfusion, a technology provider for ...

12-information-technology-stocks-moving-in-thursdays-pre-market-session
12 Information Technology Stocks Moving In...
03/14/2024 13:06:04

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION